Corcept Therapeutics Inc (CORT)
24.00
+0.06 (+0.25%)
USD |
NASDAQ |
Feb 02, 09:51
Corcept Therapeutics Market Cap: 2.571B for Feb. 2, 2023
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| February 01, 2023 | 2.564B |
| January 31, 2023 | 2.448B |
| January 30, 2023 | 2.462B |
| January 27, 2023 | 2.491B |
| January 26, 2023 | 2.457B |
| January 25, 2023 | 2.504B |
| January 24, 2023 | 2.439B |
| January 23, 2023 | 2.589B |
| January 20, 2023 | 2.563B |
| January 19, 2023 | 2.536B |
| January 18, 2023 | 2.516B |
| January 17, 2023 | 2.456B |
| January 13, 2023 | 2.403B |
| January 12, 2023 | 2.341B |
| January 11, 2023 | 2.251B |
| January 10, 2023 | 2.237B |
| January 09, 2023 | 2.198B |
| January 06, 2023 | 2.211B |
| January 05, 2023 | 2.196B |
| January 04, 2023 | 2.168B |
| January 03, 2023 | 2.160B |
| December 30, 2022 | 2.175B |
| December 29, 2022 | 2.194B |
| December 28, 2022 | 2.137B |
| December 27, 2022 | 2.143B |
| Date | Value |
|---|---|
| December 23, 2022 | 2.212B |
| December 22, 2022 | 2.206B |
| December 21, 2022 | 2.202B |
| December 20, 2022 | 2.198B |
| December 19, 2022 | 2.174B |
| December 16, 2022 | 2.152B |
| December 15, 2022 | 2.161B |
| December 14, 2022 | 2.212B |
| December 13, 2022 | 2.234B |
| December 12, 2022 | 2.232B |
| December 09, 2022 | 2.290B |
| December 08, 2022 | 2.464B |
| December 07, 2022 | 2.519B |
| December 06, 2022 | 2.448B |
| December 05, 2022 | 2.506B |
| December 02, 2022 | 2.675B |
| December 01, 2022 | 2.671B |
| November 30, 2022 | 2.708B |
| November 29, 2022 | 2.738B |
| November 28, 2022 | 2.717B |
| November 25, 2022 | 2.795B |
| November 23, 2022 | 2.784B |
| November 22, 2022 | 2.789B |
| November 21, 2022 | 2.792B |
| November 18, 2022 | 2.839B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.123B
Minimum
May 31 2019
3.567B
Maximum
Feb 08 2021
2.041B
Average
1.989B
Median
Sep 17 2020
Market Cap Benchmarks
| United Therapeutics Corp | 11.60B |
| Merck & Co Inc | 266.20B |
| Regeneron Pharmaceuticals Inc | 80.94B |
| Vertex Pharmaceuticals Inc | 78.86B |
| Durect Corp | 143.10M |
Market Cap Related Metrics
| PE Ratio | 24.00 |
| PS Ratio | 7.083 |
| PEG Ratio | 1.172 |
| Price to Book Value | 5.430 |
| Price to Free Cash Flow | 20.72 |
| Price | 24.00 |
| Earnings Yield | 4.17% |
| PEGY Ratio | 1.172 |
| Operating PE Ratio | 22.21 |
| Normalized PE Ratio | 24.00 |